Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
July 31, 2000
Primary Completion Date
July 31, 2002
Study Completion Date
July 31, 2002
Conditions
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic TumorGraft Versus Host DiseaseKidney CancerLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesNeuroblastomaOvarian CancerTesticular Germ Cell Tumor
Interventions
DRUG
beclomethasone dipropionate
Trial Locations (1)
98109
Fred Hutchinson Cancer Research Center, Seattle
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Fred Hutchinson Cancer Center
OTHER
NCT00010283 - Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon | Biotech Hunter | Biotech Hunter